Type I interferons promote severe disease in a mouse model of lethal ehrlichiosis

Infection and Immunity

Volumn 82, Issue 4, 2014, Pages 1698-1709

  Zhang, Yubin ^a   Thai, Vinh ^a   McCabe, Amanda ^a   Jones, Maura ^b   MacNamara, Katherine C ^a  

^a ALBANY MEDICAL COLLEGE   (United States)

^b UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA INTERFERON; ALPHA INTERFERON RECEPTOR; BETA INTERFERON; BETA INTERFERON RECEPTOR; IMMUNOGLOBULIN M;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BACTERIAL LOAD; CHIMERA; CONTROLLED STUDY; CYTOKINE PRODUCTION; DISEASE SEVERITY; EHRLICHIA MURIS; EHRLICHIOSIS; HEMATOPOIETIC CELL; IXODES; IXODES OVATUS; MONOCYTE; MOUSE; MOUSE MODEL; NONHUMAN; PATHOGENESIS; PLASMACYTOID DENDRITIC CELL; PRIORITY JOURNAL; PROTEIN FUNCTION; SIGNAL TRANSDUCTION; SURVIVAL; WILD TYPE;

ANALYSIS OF VARIANCE; ANIMALS; CD8-POSITIVE T-LYMPHOCYTES; DISEASE MODELS, ANIMAL; EHRLICHIA; EHRLICHIOSIS; IMMUNOGLOBULIN M; INTERFERON TYPE I; INTERFERON-ALPHA; INTERFERON-GAMMA; MICE; MICE, INBRED C57BL;

EID: 84896482877     PISSN: 00199567     EISSN: 10985522     Source Type: Journal    
DOI: 10.1128/IAI.01564-13     Document Type: Article

References (68)

1. Piehler J, Thomas C, Garcia KC, Schreiber G. 2012. Structural and dynamic determinants of type I interferon receptor assembly and their functional interpretation. Immunol. Rev. 250:317-334. http://dx.doi.org/10.1111/imr.12001.
2. Gough DJ, Messina NL, Clarke CJ, Johnstone RW, Levy DE. 2012. Constitutive type I interferon modulates homeostatic balance through tonic signaling. Immunity 36:166-174. http://dx.doi.org/10.1016/j.immuni.2012.01.011.
3. Essers MA, Offner S, Blanco-Bose WE, Waibler Z, Kalinke U, Duchosal MA, Trumpp A. 2009. IFNalpha activates dormant haematopoietic stem cells in vivo. Nature 458:904-908. http://dx.doi.org/10.1038/nature07815.
4. Vogel SN, Fertsch D. 1984. Endogenous interferon production by endotoxin-responsive macrophages provides an autostimulatory differentiation signal. Infect. Immun. 45:417-423.
5. Swann JB, Hayakawa Y, Zerafa N, Sheehan KC, Scott B, Schreiber RD, Hertzog P, Smyth MJ. 2007. Type I IFN contributes to NK cell homeostasis, activation, and antitumor function. J. Immunol. 178:7540-7549.
6. Trinchieri G. 2010. Type I interferon: friend or foe? J. Exp. Med. 207: 2053-2063. http://dx.doi.org/10.1084/jem.20101664.
7. Carrero JA. 2013. Confounding roles for type I interferons during bacterial and viral pathogenesis. Int. Immunol. 25:663-669. http://dx.doi.org/10.1093/intimm/dxt050.
8. Decker T, Muller M, Stockinger S. 2005. The yin and yang of type I interferon activity in bacterial infection. Nat. Rev. Immunol. 5:675-687. http://dx.doi.org/10.1038/nri1684.
9. Rayamajhi M, Humann J, Penheiter K, Andreasen K, Lenz LL. 2010. Induction of IFN-alphabeta enables Listeria monocytogenes to suppress macrophage activation by IFN-gamma. J. Exp. Med. 207:327-337. http://dx.doi.org/10.1084/jem.20091746.
10. Brzoza-Lewis KL, Hoth JJ, Hiltbold EM. 2012. Type I interferon signaling regulates the composition of inflammatory infiltrates upon infection with Listeria monocytogenes. Cell. Immunol. 273:41-51. http://dx.doi.org/10.1016/j.cellimm.2011.11.008.
11. Robinson N, McComb S, Mulligan R, Dudani R, Krishnan L, Sad S. 2012. Type I interferon induces necroptosis in macrophages during infection with Salmonella enterica serovar Typhimurium. Nat. Immunol. 13: 954-962. http://dx.doi.org/10.1038/ni.2397.
12. Mancuso G, Midiri A, Biondo C, Beninati C, Zummo S, Galbo R, Tomasello F, Gambuzza M, Macri G, Ruggeri A, Leanderson T, Teti G. 2007. Type I IFN signaling is crucial for host resistance against different species of pathogenic bacteria. J. Immunol. 178:3126-3133.
13. Del Fresno C, Soulat D, Roth S, Blazek K, Udalova I, Sancho D, Ruland J, Ardavin C. 2013. Interferon-beta production via dectin-1-Syk-IRF5 signaling in dendritic cells is crucial for immunity to C. albicans. Immunity 38:1176-1186. http://dx.doi.org/10.1016/j.immuni.2013.05.010.
14. Buchmeier NA, Schreiber RD. 1985. Requirement of endogenous interferon-gamma production for resolution of Listeria monocytogenes infection. Proc. Natl. Acad. Sci. U. S. A. 82:7404-7408. http://dx.doi.org/10.1073/pnas.82.21.7404.
15. Flynn JL, Chan J, Triebold KJ, Dalton DK, Stewart TA, Bloom BR. 1993. An essential role for interferon gamma in resistance to Mycobacterium tuberculosis infection. J. Exp. Med. 178:2249-2254. http://dx.doi.org/10.1084/jem.178.6.2249.
16. MacNamara KC, Oduro K, Martin O, Jones DD, McLaughlin M, Choi K, Borjesson DL, Winslow GM. 2011. Infection-induced myelopoiesis during intracellular bacterial infection is critically dependent upon IFNgamma signaling. J. Immunol. 186:1032-1043. http://dx.doi.org/10.4049/jimmunol.1001893.
17. Teles RM, Graeber TG, Krutzik SR, Montoya D, Schenk M, Lee DJ, Komisopoulou E, Kelly Scumpia K, Chun R, Iyer SS, Sarno EN, Rea TH, Hewison M, Adams JS, Popper SJ, Relman DA, Stenger S, Bloom BR, Cheng G, Modlin RL. 2013. Type I interferon suppresses type II interferon-triggered human anti-mycobacterial responses. Science 339: 1448-1453. http://dx.doi.org/10.1126/science.1233665.
18. Berry MP, Graham CM, McNab FW, Xu Z, Bloch SA, Oni T, Wilkinson KA, Banchereau R, Skinner J, Wilkinson RJ, Quinn C, Blankenship D, Dhawan R, Cush JJ, Mejias A, Ramilo O, Kon OM, Pascual V, Banchereau J, Chaussabel D, O'Garra A. 2010. An interferon-inducible neutrophil-driven blood transcriptional signature in human tuberculosis. Nature 466:973-977. http://dx.doi.org/10.1038/nature09247.
19. Manca C, Tsenova L, Freeman S, Barczak AK, Tovey M, Murray PJ, Barry C, Kaplan G. 2005. Hypervirulent M. tuberculosis W/Beijing strains upregulate type I IFNs and increase expression of negative regulators of the Jak-Stat pathway. J. Interferon Cytokine Res. 25:694-701. http://dx.doi.org/10.1089/jir.2005.25.694.
20. Manca C, Tsenova L, Bergtold A, Freeman S, Tovey M, Musser JM, Barry CE, III, Freedman VH, Kaplan G. 2001. Virulence of a Mycobacterium tuberculosis clinical isolate in mice is determined by failure to induce Th1 type immunity and is associated with induction of IFN-alpha/beta. Proc. Natl. Acad. Sci. U. S. A. 98:5752-5757. http://dx.doi.org/10.1073/pnas.091096998.
21. Hamburg BJ, Storch GA, Micek ST, Kollef MH. 2008. The importance of early treatment with doxycycline in human ehrlichiosis. Medicine 87: 53-60. http://dx.doi.org/10.1097/MD.0b013e318168da1d.
22. Kirkland KB, Wilkinson WE, Sexton DJ. 1995. Therapeutic delay and mortality in cases of Rocky Mountain spotted fever. Clin. Infect. Dis. 20:1118-1121. http://dx.doi.org/10.1093/clinids/20.5.1118.
23. Pritt BS, Sloan LM, Johnson DK, Munderloh UG, Paskewitz SM, McElroy KM, McFadden JD, Binnicker MJ, Neitzel DF, Liu G, Nicholson WL, Nelson CM, Franson JJ, Martin SA, Cunningham SA, Steward CR, Bogumill K, Bjorgaard ME, Davis JP, McQuiston JH, Warshauer DM, Wilhelm MP, Patel R, Trivedi VA, Eremeeva ME. 2011. Emergence of a new pathogenic Ehrlichia species, Wisconsin and Minnesota, 2009. N. Engl. J. Med. 365:422-429. http://dx.doi.org/10.1056/NEJMoa1010493.
24. Walker DH, Ismail N, Olano JP, McBride JW, Yu XJ, Feng HM. 2004. Ehrlichia chaffeensis: a prevalent, life-threatening, emerging pathogen. Trans. Am. Clin. Climatol. Assoc. 115:375-382; discussion 382-374.
25. Feng HM, Walker DH. 2004. Mechanisms of immunity to Ehrlichia muris: a model of monocytotropic ehrlichiosis. Infect. Immun. 72:966-971. http://dx.doi.org/10.1128/IAI.72.2.966-971.2004.
26. Shibata S, Kawahara M, Rikihisa Y, Fujita H, Watanabe Y, Suto C, Ito T. 2000. New Ehrlichia species closely related to Ehrlichia chaffeensis isolated from Ixodes ovatus ticks in Japan. J. Clin. Microbiol. 38:1331-1338.
27. Sotomayor EA, Popov VL, Feng HM, Walker DH, Olano JP. 2001. Animal model of fatal human monocytotropic ehrlichiosis. Am. J. Pathol. 158:757-769. http://dx.doi.org/10.1016/S0002-9440(10)64018-7.
28. Ismail N, Soong L, McBride JW, Valbuena G, Olano JP, Feng HM, Walker DH. 2004. Overproduction of TNF-alpha by CD8+ type 1 cells and down-regulation of IFN-gamma production by CD4+ Th1 cells con-tribute to toxic shock-like syndrome in an animal model of fatal monocytotropic ehrlichiosis. J. Immunol. 172:1786-1800.
29. Ismail N, Stevenson HL, Walker DH. 2006. Role of tumor necrosis factor alpha (TNF-alpha) and interleukin-10 in the pathogenesis of severe murine monocytotropic ehrlichiosis: increased resistance of TNF receptor p55-and p75-deficient mice to fatal ehrlichial infection. Infect. Immun. 74:1846-1856. http://dx.doi.org/10.1128/IAI.74.3.1846-1856.2006.
30. Bitsaktsis C, Winslow G. 2006. Fatal recall responses mediated by CD8 T cells during intracellular bacterial challenge infection. J. Immunol. 177: 4644-4651.
31. Duprez L, Takahashi N, Van Hauwermeiren F, Vandendriessche B, Goossens V, Vanden Berghe T, Declercq W, Libert C, Cauwels A, Vandenabeele P. 2011. RIP kinase-dependent necrosis drives lethal systemic inflammatory response syndrome. Immunity 35:908-918. http://dx.doi.org/10.1016/j.immuni.2011.09.020.
32. Kimura K, Taguchi T, Urushizaki I, Ohno R, Abe O, Furue H, Hattori T, Ichihashi H, Inoguchi K, Majima H, Niitani H, Ota K, Saito T, Suga S, Suzuoki Y, Wakui A, Yamada K, The A-TNF Cooperative Study Group. 1987. Phase I study of recombinant human tumor necrosis factor. Cancer Chemother. Pharmacol. 20:223-229. http://dx.doi.org/10.1007/BF00570490.
33. Thirumalapura NR, Stevenson HL, Walker DH, Ismail N. 2008. Protective heterologous immunity against fatal ehrlichiosis and lack of protection following homologous challenge. Infect. Immun. 76:1920-1930. http://dx.doi.org/10.1128/IAI.01293-07.
34. Bitsaktsis C, Huntington J, Winslow G. 2004. Production of IFN-gamma by CD4 T cells is essential for resolving Ehrlichia infection. J. Immunol. 172:6894-6901.
35. Racine R, Chatterjee M, Winslow GM. 2008. CD11c expression identifies a population of extrafollicular antigen-specific splenic plasmablasts responsible for CD4 T-independent antibody responses during intracellular bacterial infection. J. Immunol. 181:1375-1385.
36. Racine R, McLaughlin M, Jones DD, Wittmer ST, MacNamara KC, Woodland DL, Winslow GM. 2011. IgM production by bone marrow plasmablasts contributes to long-term protection against intracellular bacterial infection. J. Immunol. 186:1011-1021. http://dx.doi.org/10.4049/jimmunol.1002836.
37. Ismail N, Crossley EC, Stevenson HL, Walker DH. 2007. Relative importance of T-cell subsets in monocytotropic ehrlichiosis: a novel effector mechanism involved in Ehrlichia-induced immunopathology in murine ehrlichiosis. Infect. Immun. 75:4608-4620. http://dx.doi.org/10.1128/IAI.00198-07.
38. Stevenson HL, Crossley EC, Thirumalapura N, Walker DH, Ismail N. 2008. Regulatory roles of CD1d-restricted NKT cells in the induction of toxic shock-like syndrome in an animal model of fatal ehrlichiosis. Infect. Immun. 76:1434-1444. http://dx.doi.org/10.1128/IAI.01242-07.
39. Yang Q, Ghose P, Ismail N. 2013. Neutrophils mediate immunopathology and negatively regulate protective immune responses during fatal bacterial infection-induced toxic shock. Infect. Immun. 81:1751-1763. http://dx.doi.org/10.1128/IAI.01409-12.
40. MacNamara KC, Racine R, Chatterjee M, Borjesson D, Winslow GM. 2009. Diminished hematopoietic activity associated with alterations in innate and adaptive immunity in a mouse model of human monocytic ehrlichiosis. Infect. Immun. 77:4061-4069. http://dx.doi.org/10.1128/IAI.01550-08.
41. Liu F, Whitton JL. 2005. Cutting edge: re-evaluating the in vivo cytokine responses of CD8+ T cells during primary and secondary viral infections. J. Immunol. 174:5936-5940.
42. Nandi B, Hogle K, Vitko N, Winslow GM. 2007. CD4 T-cell epitopes associated with protective immunity induced following vaccination of mice with an ehrlichial variable outer membrane protein. Infect. Immun. 75:5453-5459. http://dx.doi.org/10.1128/IAI.00713-07.
43. Zhang Y, Jones M, McCabe A, Winslow GM, Avram D, MacNamara KC. 2013. MyD88 signaling in CD4 T cells promotes IFN-gamma production and hematopoietic progenitor cell expansion in response to intracellular bacterial infection. J. Immunol. 190:4725-4735. http://dx.doi.org/10.4049/jimmunol.1203024.
44. Chattoraj P, Yang Q, Khandai A, Al-Hendy O, Ismail N. 2013. TLR2 and Nod2 mediate resistance or susceptibility to fatal intracellular Ehrlichia infection in murine models of ehrlichiosis. PLoS One 8:e58514. http://dx.doi.org/10.1371/journal.pone.0058514.
45. Schwandt T, Schumak B, Gielen GH, Jungerkes F, Schmidbauer P, Klocke K, Staratschek-Jox A, van Rooijen N, Kraal G, Ludwig-Portugall I, Franken L, Wehner S, Kalff JC, Weber O, Kirschning C, Coch C, Kalinke U, Wenzel J, Kurts C, Zawatzky R, Holzmann B, Layland L, Schultze JL, Burgdorf S, den Haan JM, Knolle PA, Limmer A. 2012. Expression of type I interferon by splenic macrophages suppresses adaptive immunity during sepsis. EMBO J. 31:201-213. http://dx.doi.org/10.1038/emboj.2011.380.
46. Cervantes-Barragan L, Zust R, Weber F, Spiegel M, Lang KS, Akira S, Thiel V, Ludewig B. 2007. Control of coronavirus infection through plasmacytoid dendritic-cell-derived type I interferon. Blood 109:1131-1137.
47. Ng D, Gommerman JL. 2013. The regulation of immune responses by DC derived type I IFN. Front. Immunol. 4:94. http://dx.doi.org/10.3389/fimmu.2013.00094.
48. Wendland M, Czeloth N, Mach N, Malissen B, Kremmer E, Pabst O, Forster R. 2007. CCR9 is a homing receptor for plasmacytoid dendritic cells to the small intestine. Proc. Natl. Acad. Sci. U. S. A. 104:6347-6352. http://dx.doi.org/10.1073/pnas.0609180104.
49. Zhang J, Raper A, Sugita N, Hingorani R, Salio M, Palmowski MJ, Cerundolo V, Crocker PR. 2006. Characterization of Siglec-H as a novel endocytic receptor expressed on murine plasmacytoid dendritic cell precursors. Blood 107:3600-3608. http://dx.doi.org/10.1182/blood-2005-09-3842.
50. Barchet W, Cella M, Colonna M. 2005. Plasmacytoid dendritic cells-virus experts of innate immunity. Semin. Immunol. 17:253-261. http://dx.doi.org/10.1016/j.smim.2005.05.008.
51. Scheu S, Dresing P, Locksley RM. 2008. Visualization of IFNbeta production by plasmacytoid versus conventional dendritic cells under specific stimulation conditions in vivo. Proc. Natl. Acad. Sci. U. S. A. 105:20416-20421. http://dx.doi.org/10.1073/pnas.0808537105.
52. Wajant H, Pfizenmaier K, Scheurich P. 2003. Tumor necrosis factor signaling. Cell Death Differ. 10:45-65. http://dx.doi.org/10.1038/sj.cdd.4401189.
53. Huys L, Van Hauwermeiren F, Dejager L, Dejonckheere E, Lienenklaus S, Weiss S, Leclercq G, Libert C. 2009. Type I interferon drives tumor necrosis factor-induced lethal shock. J. Exp. Med. 206:1873-1882. http://dx.doi.org/10.1084/jem.20090213.
54. Nguyen KB, Cousens LP, Doughty LA, Pien GC, Durbin JE, Biron CA. 2000. Interferon alpha/beta-mediated inhibition and promotion of interferon gamma: STAT1 resolves a paradox. Nat. Immunol. 1:70-76. http://dx.doi.org/10.1038/76940.
55. Nakano M, Fujii T, Hashimoto M, Yukawa N, Yoshifuji H, Ohmura K, Nakaizumi A, Mimori T. 2012. Type I interferon induces CX3CL1 (fractalkine) and CCL5 (RANTES) production in human pulmonary vascular endothelial cells. Clin. Exp. Immunol. 170:94-100. http://dx.doi.org/10.1111/j.1365-2249.2012.04638.x.
56. Gong B, Ma L, Liu Y, Gong Q, Shelite T, Bouyer D, Boor PJ, Lee YS, Oberhauser A. 2012. Rickettsiae induce microvascular hyperpermeability via phosphorylation of VE-cadherins: evidence from atomic force microscopy and biochemical studies. PLoS Negl. Trop. Dis. 6:e1699. http://dx.doi.org/10.1371/journal.pntd.0001699.
57. Wang Y, Pampou S, Fujikawa K, Varticovski L. 2004. Opposing effect of angiopoietin-1 on VEGF-mediated disruption of endothelial cell-cell interactions requires activation of PKC beta. J. Cell. Physiol. 198:53-61. http://dx.doi.org/10.1002/jcp.10386.
58. Fiedler U, Reiss Y, Scharpfenecker M, Grunow V, Koidl S, Thurston G, Gale NW, Witzenrath M, Rosseau S, Suttorp N, Sobke A, Herrmann M, Preissner KT, Vajkoczy P, Augustin HG. 2006. Angiopoietin-2 sensitizes endothelial cells to TNF-alpha and has a crucial role in the induction of inflammation. Nat. Med. 12:235-239. http://dx.doi.org/10.1038/nm1351.
59. Ghosh CC, Mukherjee A, David S, Knaus UG, Stearns-Kurosawa DJ, Kurosawa S, Parikh SM. 2012. Impaired function of the Tie-2 receptor contributes to vascular leakage and lethality in anthrax. Proc. Natl. Acad. Sci. U. S. A. 109:10024-10029. http://dx.doi.org/10.1073/pnas.1120755109.
60. Michels M, van der Ven AJ, Djamiatun K, Fijnheer R, de Groot PG, Griffioen AW, Sebastian S, Faradz SM, de Mast Q. 2012. Imbalance of angiopoietin-1 and angiopoetin-2 in severe dengue and relationship with thrombocytopenia, endothelial activation, and vascular stability. Am. J. Trop. Med. Hyg. 87:943-946. http://dx.doi.org/10.4269/ajtmh.2012.12-0020.
61. Venkatesh D, Ernandez T, Rosetti F, Batal I, Cullere X, Luscinskas FW, Zhang Y, Stavrakis G, Garcia-Cardena G, Horwitz BH, Mayadas TN. 2013. Endothelial TNF receptor 2 induces IRF1 transcription factordependent interferon-beta autocrine signaling to promote monocyte re-cruitment. Immunity 38:1025-1037. http://dx.doi.org/10.1016/j.immuni.2013.01.012.
62. Pawlotsky JM. 2013. Treatment of chronic hepatitis C: current and future. Curr. Top. Microbiol. Immunol. 369:321-342.
63. Tarhini AA, Gogas H, Kirkwood JM. 2012. IFN-alpha in the treatment of melanoma. J. Immunol. 189:3789-3793. http://dx.doi.org/10.4049/jimmunol.1290060.
64. Blick M, Sherwin SA, Rosenblum M, Gutterman J. 1987. Phase I study of recombinant tumor necrosis factor in cancer patients. Cancer Res. 47: 2986-2989.
65. Barber GN. 2011. Innate immune DNA sensing pathways: STING, AIMII and the regulation of interferon production and inflammatory responses. Curr. Opin. Immunol. 23:10-20. http://dx.doi.org/10.1016/j.coi.2010.12.015.
66. de Almeida LA, Carvalho NB, Oliveira FS, Lacerda TL, Vasconcelos AC, Nogueira L, Bafica A, Silva AM, Oliveira SC. 2011. MyD88 and STING signaling pathways are required for IRF3-mediated IFN-beta induction in response to Brucella abortus infection. PLoS One 6:e23135. http://dx.doi.org/10.1371/journal.pone.0023135.
67. Stockinger S, Kastner R, Kernbauer E, Pilz A, Westermayer S, Reutterer B, Soulat D, Stengl G, Vogl C, Frenz T, Waibler Z, Taniguchi T, Rulicke T, Kalinke U, Muller M, Decker T. 2009. Characterization of the interferon-producing cell in mice infected with Listeria monocytogenes. PLoS Pathog. 5:e1000355. http://dx.doi.org/10.1371/journal.ppat.1000355.
68. Stanley SA, Johndrow JE, Manzanillo P, Cox JS. 2007. The type I IFN response to infection with Mycobacterium tuberculosis requires ESX-1-mediated secretion and contributes to pathogenesis. J. Immunol. 178: 3143-3152.